Bilateral Low-Energy Simultaneous or Sequential Femoral Fractures in Patients on Long-Term Alendronate Therapy

Capeci, Craig M.; Tejwani, Nirmal C.
November 2009
Journal of Bone & Joint Surgery, American Volume;Nov2009, Vol. 91-A Issue 11, p2556
Academic Journal
Background: While alendronate therapy has been shown to decrease the risk of vertebral and femoral neck fractures in postmenopausal osteoporotic patients, recent reports have associated long-term alendronate therapy with unilateral low-energy subtrochanteric and diaphyseal femoral fractures in a small number of patients. To our knowledge, there has been only one report of sequential bilateral femoral fractures in patients on long-term bisphosphonate therapy. Methods: We retrospectively reviewed the case log of the senior author over the last four years to identify patients who presented with a subtrochanteric or diaphyseal femoral fracture after a low-energy mechanism of injury (a fall from standing height or less) and who had been taking alendronate for more than five years. Radiographs were reviewed, and the fracture patterns were recorded. Serum calcium levels were recorded when available. Results: Seven patients who sustained low-energy bilateral subtrochanteric or diaphyseal femoral fractures while on long-term alendronate therapy were identified. One patient presented with simultaneous bilateral diaphyseal fractures, two patients had sequential subtrochanteric fractures, and four patients had impending contralateral subtrochanteric stress fractures noted at the time of the initial fracture. Of the latter four, one patient had a fracture through the stress site and the other three patients had prophylactic stabilization of the site with internal fixation. No patient had discontinued alendronate therapy prior to the second fracture. All patients were women with an average age of sixty-one years, and they had been on alendronate therapy for an average of 8.6 years. All fractures were treated with reamed intramedullary nailing and went on to union at an average of four months. Conclusions: In patients on long-term alendronate therapy who present with a subtrochanteric or diaphyseal femoral fracture, we recommend radiographs of the contralateral femur and consideration of discontinuing alendronate in consultation with an endocrinologist. If a contralateral stress fracture is found, prophylactic fixation should be considered. Level of Evidence: Prognostic Level IV. See Instructions to Authors for a complete description of levels of evidence.


Related Articles

  • Cumulative incidence and treatment of non-simultaneous bilateral femoral neck fractures in a cohort of one thousand two hundred and fifty patients. Burgers, Paul; Zielinski, Stephanie; Mailuhu, Adinda; Heetveld, Martin; Verhofstad, Michiel; Roukema, Gert; Patka, Peter; Poolman, Rudolf; Lieshout, Esther // International Orthopaedics;Nov2014, Vol. 38 Issue 11, p2335 

    Purpose: In the Netherlands, over 20,000 patients sustain a hip fracture yearly. A first hip fracture is a risk factor for a second, contralateral fracture. Data on the similarity of the treatment of bilateral femoral neck fractures is only scarcely available. The objectives of this study were...

  • Healing Delayed But Generally Reliable After Bisphosphonate-associated Complete Femur Fractures Treated with IM Nails. Egol, Kenneth; Park, Ji; Rosenberg, Zehava; Peck, Valerie; Tejwani, Nirmal // Clinical Orthopaedics & Related Research;Sep2014, Vol. 472 Issue 9, p2728 

    Background: Bisphosphonate therapy for osteoporosis has been associated with atypical femoral fractures. To date, there have been few reports in the literature regarding the preoperative and postoperative courses of patients who have sustained bisphosphonate-associated complete atypical femur...

  • Atypical femoral fracture in a patient treated with denosumab. Khow, Kareeann; Yong, Tuck // Journal of Bone & Mineral Metabolism;May2015, Vol. 33 Issue 3, p355 

    Atypical fractures of the femur (AFF) have been reported in the literature at an increasing rate over the past decade, especially in patients who have been on prolonged courses of bisphosphonates. However, there have only been a few reported cases of AFF in those treated with other...

  • Alendronic acid.  // Reactions Weekly;11/26/2011, Issue 1379, p7 

    The article describes the case of a 55-year-old woman reported in April 2009, with a three-month history of bilateral thigh pain, who developed atypical femoral fractures and bone turnover after receiving alendronic acid five milligrams daily for nine years.

  • Alendronic acid/ibandronic acid/risedronic acid.  // Reactions Weekly;6/19/2010, Issue 1306, p8 

    The article describes the case of four post-menopausal women who experienced proximal femoral insuffiency fractures while receiving long-term treatment with oral bisphosphonates, published in the April 2010 issue of the "American Journal of Roentgenology."

  • Intramedullary Pinning and use of Cerclage Wires for the Management of Diaphyseal Comminuted Femoral Fracture in a Dog. Singh, D. K.; Saha, M. K. // Intas Polivet;jul-dec2012, Vol. 13 Issue 2, p420 

    A one year old male dog sustained diaphyseal comminuted femoral fracture due to accident with car. The diagnosis was made by latero-medial radiographic evaluation. The fracture was stabilized by intramedullary pinning and use of cerclage wires. Intramedullary pin was removed after taking...

  • Cross-pinning and Lag-screw Compression for the Management of Supracondylar and Intercondylar Femoral Fracture in a Dog. Raghunath, M.; Bishnoi, A. K.; Mohindroo, J.; Prabhakar, V. // Intas Polivet;jul-dec2012, Vol. 13 Issue 2, p416 

    An intact 22 months old Dachshund bitch was radiographically diagnosed with complete, displaced, oblique supracondylar fracture with the concurrent intercondylar component of the left femur. After open reduction the splayed fractured condyles were stabilized and compressed using cortical screw...

  • Treatment of Trochanteric Fractures with the PFNA (Proximal Femoral Nail Antirotation) Nail System. Takigami, Iori; Matsumoto, Kazu; Ohara, Akira; Yamanaka, Kazuteru; Naganawa, Toshitaka; Ohashi, Minoru; Date, Kazuto; Shimizu, Katsuji // Bulletin of the NYU Hospital for Joint Diseases;2008, Vol. 66 Issue 4, p276 

    Currently, intramedullary devices are widely used for the treatment of trochanteric femoral fractures. A new device designed by AO/ASIF the PFNA (proximal femoral nail antirotation), represents a unique intramedullary nail system for improved management, particularly in the elderly. The aim of...

  • Evaluation of complications of three different types of proximal extra-articular femur fractures. Suckel, Andreas; Dietz, Klaus; Wuelker, Nikolaus; Helwig, Peter // International Orthopaedics;Oct2007, Vol. 31 Issue 5, p689 

    The comparability of studies of extra-articular proximal femur fractures is compromised by the lack of a widely accepted, simple classification system with clinical and prognostic relevance. The aim of the study is to define the complication profile as well as differences relating to age, gender...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics